Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease P

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Dec 13, 2020 4:24pm

195 Views

Post# 32096322

RE:RE:RE:RE:RE:RE:AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease P

mrfisherking wrote: According to the TLT website, Theralase shares (204 million-ish) plus warrants (72 million-ish) plus options (14.5 million) are fully diluted at roughly 291 million, which would mean the stock price would be roughly $3.40 for every billion valuation. And i guess it matters if that billion is in American or Canadian currency as well... as i read it.

thanks,it would probably be American

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it